Vanguard Group’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.09B | Sell |
48,059,731
-526,977
| -1% | -$11.5M | 0.02% | 677 |
|
|
2025
Q3 | $979M | Buy |
48,586,708
+759,623
| +2% | +$12.7M | 0.01% | 716 |
|
|
2025
Q2 | $683M | Sell |
47,827,085
-496,161
| -1% | -$5.8M | 0.01% | 852 |
|
|
2025
Q1 | $507M | Sell |
48,323,246
-437,731
| -0.9% | -$4.95M | 0.01% | 986 |
|
|
2024
Q4 | $590M | Sell |
48,760,977
-184,506
| -0.4% | -$2.41M | 0.01% | 942 |
|
|
2024
Q3 | $719M | Sell |
48,945,483
-502,330
| -1% | -$7M | 0.01% | 825 |
|
|
2024
Q2 | $714M | Buy |
49,447,813
+189,573
| +0.4% | +$3.03M | 0.01% | 788 |
|
|
2024
Q1 | $802M | Sell |
49,258,240
-210,397
| -0.4% | -$3.29M | 0.02% | 750 |
|
|
2023
Q4 | $737M | Buy |
49,468,637
+467,196
| +1% | +$5.29M | 0.02% | 759 |
|
|
2023
Q3 | $551M | Buy |
49,001,441
+362,152
| +0.7% | +$4.21M | 0.01% | 846 |
|
|
2023
Q2 | $489M | Buy |
48,639,289
+2,314,726
| +5% | +$21.5M | 0.01% | 937 |
|
|
2023
Q1 | $435M | Buy |
46,324,563
+632,725
| +1% | +$7.46M | 0.01% | 987 |
|
|
2022
Q4 | $558M | Buy |
45,691,838
+3,015,401
| +7% | +$37.6M | 0.02% | 817 |
|
|
2022
Q3 | $530M | Buy |
42,676,437
+200,259
| +0.5% | +$3.5M | 0.02% | 804 |
|
|
2022
Q2 | $834M | Buy |
42,476,178
+1,023,648
| +2% | +$24.2M | 0.02% | 620 |
|
|
2022
Q1 | $1.08B | Buy |
41,452,530
+650,715
| +2% | +$17.3M | 0.03% | 610 |
|
|
2021
Q4 | $1.16B | Sell |
40,801,815
-58,573
| -0.1% | -$1.82M | 0.03% | 606 |
|
|
2021
Q3 | $1.3B | Sell |
40,860,388
-1,658,702
| -4% | -$55.7M | 0.03% | 551 |
|
|
2021
Q2 | $1.47B | Buy |
42,519,090
+372,791
| +0.9% | +$12.3M | 0.04% | 513 |
|
|
2021
Q1 | $1.24B | Buy |
42,146,299
+414,237
| +1% | +$12.7M | 0.03% | 547 |
|
|
2020
Q4 | $1.28B | Buy |
41,732,062
+2,217,632
| +6% | +$67.7M | 0.04% | 499 |
|
|
2020
Q3 | $1.1B | Buy |
39,514,430
+2,389,161
| +6% | +$60.5M | 0.04% | 492 |
|
|
2020
Q2 | $796M | Sell |
37,125,269
-846,657
| -2% | -$18.7M | 0.03% | 575 |
|
|
2020
Q1 | $850M | Buy |
37,971,926
+3,894,200
| +11% | +$107M | 0.04% | 487 |
|
|
2019
Q4 | $1B | Buy |
34,077,726
+243,817
| +0.7% | +$6.63M | 0.03% | 543 |
|
|
2019
Q3 | $900M | Buy |
33,833,909
+1,891,646
| +6% | +$56.7M | 0.03% | 550 |
|
|
2019
Q2 | $1.08B | Buy |
31,942,263
+2,955,748
| +10% | +$96M | 0.04% | 495 |
|
|
2019
Q1 | $930M | Buy |
28,986,515
+22,735,630
| +364% | +$700M | 0.04% | 525 |
|
|
2018
Q4 | $197M | Buy |
6,250,885
+1,201,238
| +24% | +$39.3M | 0.01% | 1252 |
|
|
2018
Q3 | $176M | Buy |
+5,049,647
| New | +$178M | 0.01% | 1476 |
|
Other funds holding ELAN
BCIM
